Jefferies stays bullish on S&P 500, sees 9,000 by end-2027

Jefferies set a 2026 year-end S&P 500 target of 8,000 and a 2027 target of 9,000, underpinned by forecasts for 35% and 20.8% earnings growth, respectively, versus 29% 2026 consensus growth. The firm estimates AI- and data-center-exposed companies, representing roughly 46% of the index, will deliver about 60% earnings growth in 2026, while improving earnings outside the Magnificent 7 should broaden participation. Key risks are elevated valuation at 21.5x forward earnings and higher long-term yields, with the 10-year Treasury yield already up more than 60bps this year; Jefferies' 2027 downside scenario is 6,900 versus a bull case of 10,500.

Analysis

The actionable implication is not a broad-index chase but a dispersion regime: if earnings revisions continue diffusing outside hyperscaler-linked capex, equal-weight cyclicals should close the gap with cap-weighted indices over the next 1-3 months. XLF is the cleanest beneficiary of a steeper long end through reinvestment yields, trading activity and underwriting; materials exposure via XLB benefits only if nominal growth, rather than supply disruption, is driving commodity strength. Conversely, rate-sensitive long-duration equities—especially XLRE and expensive consumer-discretionary franchises—face a double hit from discount-rate pressure and weaker household demand.

The central fragility is that AI capex is increasingly debt-funded while its revenue conversion remains uneven. A further 40bp+ rise in the 10-year Treasury yield over a quarter would likely matter more for index returns than incremental earnings upgrades, because the most crowded AI beneficiaries retain the greatest duration and concentration risk. The 6-18 month bullish case requires enterprise AI monetization to broaden beyond infrastructure spending; otherwise, a slowdown in data-center orders would simultaneously cut semiconductor/server estimates and remove the earnings support for the wider market.

The contrarian view is that broadening may occur through mega-cap underperformance rather than a sustained small- and mid-cap rally. Financials and health care have more credible revision runways at lower valuation risk, but materials need confirmation from global PMIs and Chinese demand rather than simply higher commodity prices. JEF itself has limited direct earnings sensitivity to its published market outlook; absent evidence of improved advisory, underwriting or trading volumes, this is not a standalone catalyst for the shares.

Key Decisions for Investors

• Initiate a 1-3 month pair: long XLF / short XLRE, sized beta-neutral. A persistently higher 10-year yield should widen the relative earnings and valuation gap; exit if the 10-year retraces more than 35bp or bank net-interest-income guidance weakens.
• Express breadth with long RSP versus short QQQ on a 3-6 month horizon rather than adding outright index beta. Target a 5-8% relative move; invalidate if equal-weight earnings revisions fail to improve for two consecutive monthly revision cycles.
• Maintain AI exposure but rotate marginal risk from concentrated infrastructure names into profitable software and health-care beneficiaries via overweight XLV versus underweight XLY. Reassess after the next two earnings seasons if enterprise AI revenue remains immaterial relative to capex growth.
• Do not buy JEF solely on this publication. Put the name on watch for capital-markets fee growth and advisory backlog confirmation; a meaningful acceleration in underwriting/advisory revenue, not market commentary, would be the trade catalyst.